Controlled release of human immunoglobulin G. 1. Release kinetics studies

Journal of Pharmaceutical Sciences

Volumn 88, Issue 2, 1999, Pages 215-220

  Wang, Chi Hwa ^a   Sengothi, Kamalesh ^a   Lee, Timothy ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; ETHYLENE VINYL ACETATE COPOLYMER; IMMUNOGLOBULIN G; MICROSPHERE; POLYMER;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TRANSPORT;

EID: 0032969136     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9803407     Document Type: Article

References (28)

1. Dwyer, J. M. Thirty years of supplying the missing link. Am. J. Med. 1984, 76, 46-52.
2. French, M. A. H. Serum immunoglobulins in disease diagnosis and management. In Immunoglobulins in Health and Disease; French, M. A. H., Ed.; MTP Press Ltd.: Lancaster, England, 1986; pp 123-142.
3. Jain, R. K. Physiological barriers to delivery of Monoclonal antibodies and other macromolecules in tumors. Cancer Res. (Suppl) 1990, 50, 814s-819s.
4. Hochberg, F. H.; Pruitt, A. Assumptions in the radiotherapy of gliobastoma. Neurology 1980, 30, 907-911.
5. Langer, R. S.; Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976, 263, 797-799.
6. Kuo, P. Y.; Sherwood, J. K.; Saltzman, W. M. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood. Nature Biotech. 1998, 16, 163-167.
7. Cleek, R. L.; Ting, K. C.; Eskin, S. G.; Mikos, A. G. Microparticles of poly (DL-lactic-co-glycolic acid)/poly (ethylene glycol) blends for controlled drug delivery. J. Controlled Release 1997, 48, 259-268.
8. Langer, R. S.; Brem, H.; Tapper, D. Biocompatibility of polymeric delivery systems for macromolecules. J. Biomed. Mater. Res. 1981, 15, 267-277.
9. Yang, M. B.; Tarmargo, R. J.; Brem, H. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. Cancer Res. 1989, 49, 5103-5107.
10. Fulton, S. P.; Meys, M.; Varady, L.; Jansen, R.; Afeyan, N. B. Antibody quantitation in seconds using affinity perfusion chromatography. BioTechniques 1991, 11, 226-231.
11. Sefton, M. V.; Brown, L. R.; Langer, R. S. Ethylene vinyl acetate copolymer microspheres for controlled release of macromolecules. J. Pharm. Sci. 1984, 73, 1859-1861.
12. Rhine, W. D.; Hsieh, D. S. T.; Langer, R. S. Polymers for sustained macromolecular release: Procedures to fabricate reproducible delivery systems and control release kinetics. J. Pharm. Sci. 1980, 69, 265-269.
13. Crank, J. The mathematics of diffusion, 2nd ed.; Clarendon Press: Oxford, England, 1975.
14. Vergnaud, J. M. Liquid transport processes in polymeric materials; Prentice Hall, Inc.: New Jersey, 1991.
15. Vergnaud, J. M. Controlled Drug Release of Oral Dosage Forms; Ellis Horwood Ltd.: West Sussex, England, 1993.
16. Gurny, R.; Doelker, E.; Peppas, N. A. Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers. Biomaterials 1982, 3, 27-32.
17. Hsieh, D. S. T.; Rhine, W. D.; Langer, R. S. Zero-order controlled release polymer matrixes for micro- and macromolecules. J. Pharm. Sci. 1983, 72, 17-22.
18. Pirofsky, B. Intravenous Immunoglobulin therapy in hypogammaglobulinemia. Am. J. Med. 1984, 76, 53-60.
19. Saltzman, W. M.; Sheppard, N. F.; McHugh, M. A.; Dause, R. B.; Pratt, J. A.; Dodrill, A. M. Controlled antibody release from a matrix of poly (ethylene-co-vinyl acetate) fractionated with a supercritical fluid. J. Appl. Polym. Sci. 1993, 48, 1493-1500.
20. Radomsky, M. L.; Whaley, K. J.; Cone, R. A.; Saltzman, W. M. Macromolecules released from polymers: diffusion into unstirred fluids. Biomaterials 1990, 11, 619-624.
21. Saltzman, W. M.; Langer, R. S. Transport rates of proteins in porous materials with known microgeometry. Biophys. J. 1989, 55, 163-171.
22. Miller, E. S.; Peppas, N. A. Diffusional release of water-soluble bioactive agents from ethylene vinyl acetate copolymers. Pharm. Res. 1983, 22, 303-315.
23. Immune Globulin intravenous (human) Venoglobulin-I lyophilized: Product information. Alpha Therapeutic Corporation: Los Angeles, CA, 1995.
24. Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. S. Controlled Delivery Systems for Proteins Based on Poly (Lactic/Glycolic Acid) Microspheres. Pharm. Res. 1991, 8, 713-720.
25. Costantino, H. R.; Griebenow, K.; Mishra, P.; Langer, R. S.; Klibanov, A. M. Fourier transform infrared spectroscopic investigation of protein stability in the lyophilized form. Biochim. Biophys. Acta. 1995, 1253, 69-74.
26. Klibanov, A. M. Why are enzymes less active in organic solvents than in water? Trends Biotechnol. 1997, 15, 97-101.
27. Guilford Pharmaceutical, Gliadel WAFER, 1995.
28. Wang, C.-H.; Li, J. Three-Dimensional Simulation of IgG Delivery to Tumors. Chem. Eng. Sci. 1998, 53, 3579-3600.